BSE Live
Apr 17, 16:00Prev. Close
634.30
Open Price
631.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 17, 15:49Prev. Close
631.10
Open Price
639.00
Bid Price (Qty.)
645.45 (55)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Sudeep Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | |
| 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||
| Revenue From Operations [Gross] | 353.45 | 340.50 | 401.60 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 353.45 | 340.50 | 401.60 | |
| Total Operating Revenues | 356.73 | 343.76 | 404.00 | |
| Other Income | 8.38 | 8.20 | 11.18 | |
| Total Revenue | 365.11 | 351.96 | 415.17 | |
| EXPENSES | ||||
| Cost Of Materials Consumed | 146.94 | 122.03 | 190.22 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -20.47 | 7.58 | -15.56 | |
| Employee Benefit Expenses | 26.06 | 20.22 | 60.79 | |
| Finance Costs | 4.81 | 2.97 | 3.84 | |
| Depreciation And Amortisation Expenses | 6.12 | 5.15 | 4.83 | |
| Other Expenses | 72.24 | 61.71 | 80.29 | |
| Total Expenses | 235.70 | 219.65 | 324.40 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 129.41 | 132.31 | 90.77 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 129.41 | 132.31 | 90.77 | |
| Tax Expenses-Continued Operations | ||||
| Current Tax | 33.13 | 34.02 | 23.19 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.53 | 0.21 | 0.41 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 33.66 | 34.23 | 23.60 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 95.75 | 98.08 | 67.17 | |
| Profit/Loss From Continuing Operations | 95.75 | 98.08 | 67.17 | |
| Profit/Loss For The Period | 95.75 | 98.08 | 67.17 | |
| OTHER ADDITIONAL INFORMATION | ||||
| EARNINGS PER SHARE | ||||
| Basic EPS (Rs.) | 8.82 | 9.04 | 476.69 | |
| Diluted EPS (Rs.) | 8.82 | 9.04 | 476.69 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 |
18.02.2026
Sudeep Pharma Consolidated December 2025 Net Sales at Rs 172.34 crore, up 49.16% Y-o-Y
22.12.2025
28.11.2025
28.11.2025